Ultragenyx Pharmaceutical
RARE
#3245
Rank
HK$27.21 B
Marketcap
HK$294.18
Share price
-2.75%
Change (1 day)
-19.98%
Change (1 year)

Earnings for Ultragenyx Pharmaceutical (RARE)

Earnings in 2024 (TTM): -HK$3.94 Billion

According to Ultragenyx Pharmaceutical's latest financial reports the company's current earnings are HK$0.56 Billion. , an increase over its 2023 earnings that were of -HK$4.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ultragenyx Pharmaceutical from 2013 to 2024

Annual earnings

Year Earnings Change
2024 -HK$3.93 Billion-6.99%
2023 -HK$4.22 Billion-17.65%
2022 -HK$5.13 Billion55.52%
2021 -HK$3.3 Billion178.53%
2020 -HK$1.19 Billion-59.64%
2019 -HK$2.94 Billion1.46%
2018 -HK$2.89 Billion12.9%
2017 -HK$2.56 Billion32.63%
2016 -HK$1.93 Billion67.87%
2015 -HK$1.15 Billion160.2%
2014 -HK$0.45 Billion66.64%
2013 -HK$0.27 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
HK$4.21 B-207.38%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$0.23 Billion-94.30%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$58.38 M-101.49%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$1.56 Billion-60.28%๐Ÿ‡บ๐Ÿ‡ธ USA